MTOR and head and neck squamous cell carcinoma: In prior studies, we have shown that metformin causes a significant reduction in the conversion of OPLs into HNSCC in mice (27) and that metformin decreases mTOR activity and HNSCC progression by acting on cancer-initiating cells directly (28, 29).